|

Heart Failure Precision Medicine Study

RECRUITINGN/ASponsored by University of California, Davis
Actively Recruiting
PhaseN/A
SponsorUniversity of California, Davis
Started2019-10-16
Est. completion2026-10-16
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04196842

Summary

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

Eligibility

Age: 21 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Heart failure
* Objective evidence of cardiac abnormality of structure or function (abnormal ECHO) or elevated levels of B-type natriuretic peptide (\>100 pg/ml)
* HF stage B-D and class I-IV

Exclusion Criteria:

* Patients unable to consent
* Inability to comply with the protocol and follow-up requirements
* Patients unable to use a smartphone
* Patients assessed irregularly (less than two visits in one year)
* History of HTx
* Use of Mechanical circulatory support device (MCSD)
* Comorbidities that, according to the PI, have the potential to interfere with the interpretation of the results

Conditions2

Heart DiseaseHeart Failure

Locations1 site

UC Davis Medical Center
Sacramento, California, 95817
Pablo Acevedo, BS916-703-2071peacevedo@ucdavis.edu

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.